Essex Savings Bank Purchases 123 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Essex Savings Bank grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 660 shares of the medical equipment provider’s stock after purchasing an additional 123 shares during the quarter. Essex Savings Bank’s holdings in Intuitive Surgical were worth $344,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Mark Sheptoff Financial Planning LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $37,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at $38,000. Finally, DT Investment Partners LLC raised its position in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 in the last three months. 0.80% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Leerink Partners lifted their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Performance

ISRG stock opened at $584.08 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $585.50. The company has a market capitalization of $208.04 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The business’s 50 day moving average price is $538.34 and its two-hundred day moving average price is $497.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.